Performance characteristics of current-generation IMMULITE

[1]  M. Hausmann,et al.  Evaluation of the Abbott ARCHITECT Toxo IgM assay. , 2009, Diagnostic microbiology and infectious disease.

[2]  J. Gangneux,et al.  Evaluation of DPC immulite 2000® Toxoplasma quantitative IgG/IgM kits for automated toxoplasmosis serology with immulite 2000® , 2009, Journal of clinical laboratory analysis.

[3]  M. De Paschale,et al.  Revision of the positive predictive value of IgM anti-Toxoplasma antibodies as an index of recent infection. , 2008, The new microbiologica.

[4]  C. Litwin,et al.  Performance characteristics of six IMMULITE 2000 TORCH assays. , 2006, American journal of clinical pathology.

[5]  H. Soleimanjahi,et al.  Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine. , 2005, Journal of virological methods.

[6]  G. Dutton,et al.  Classification system and case definitions ofToxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[7]  R. Gilbert,et al.  Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies , 2004, Epidemiology and Infection.

[8]  M. Lappalainen,et al.  Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. , 2004, Annali dell'Istituto superiore di sanita.

[9]  P. Hohlfeld,et al.  Screening for infectious diseases , 2003, Child's Nervous System.

[10]  Carey Jc,et al.  TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. , 2002 .

[11]  R. Diepersloot,et al.  Antenatal Screening for Hepatitis B and Antibodies to Toxoplasma gondii and Rubella Virus: Evaluation of Two Commercial Immunoassay Systems , 2001, Clinical Diagnostic Laboratory Immunology.

[12]  R. Diepersloot,et al.  Comparison of Immulite with Vidas for Detection of Infection in a Low-Prevalence Population of Pregnant Women in The Netherlands , 2001, Clinical Diagnostic Laboratory Immunology.

[13]  B. Fortier,et al.  Utilisation des trousses Immulite 2000 Toxoplasmose IgG® et Toxoplasmose IgM® pour le diagnostic de la toxoplasmose humaine , 2001 .

[14]  T. Lazzarotto,et al.  Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects , 1997, Clinical and diagnostic laboratory immunology.

[15]  P. Lebon,et al.  Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. , 1997, The Journal of infectious diseases.

[16]  U. Groß,et al.  Improved serological diagnosis of Toxoplasma gondii infection by detection of immunoglobulin A (IgA) and IgM antibodies against P30 by using the immunoblot technique , 1992, Journal of clinical microbiology.

[17]  O. Djurković-Djaković,et al.  High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Case report. , 1991, Gynecologic and obstetric investigation.

[18]  J. Cesbron,et al.  Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). , 1985, Clinical and experimental immunology.

[19]  H. Oberender,et al.  Persistence of IgM antibodies to cytomegalovirus-induced late antigen in pregnancy and postpartum. , 1983, Acta virologica.